Combi Putra is primarily engaged in pharmaceuticals activity. Its headquarters is located in Jawa Barat. The company was founded in 1981. Combi Putra, officially known as PT Combi Putra, is a prominent player in the Indonesian pharmaceutical industry. The company was founded by Dr. H. Komarudin, who envisioned creating a leading pharmaceutical company that would contribute significantly to public health in Indonesia. Over the years, Combi Putra has expanded its operations to include both primary and secondary business lines, focusing on the manufacturing and distribution of pharmaceutical products and health supplements. The company operates several branches across Indonesia, with a strong presence in major cities such as Jakarta, Surabaya, and Medan. Combi Putra's product portfolio includes a wide range of over-the-counter medications, prescription drugs, and health supplements. Some of their well-known product brands include CombiFlu, CombiVit, and CombiCough, which are popular among consumers for their efficacy and affordability. Combi Putra has established partnerships with various international pharmaceutical companies to enhance its product offerings and expand its market reach. The company is a member of the Indonesian Pharmaceutical Association and actively participates in industry events and forums to stay abreast of the latest developments in the pharmaceutical sector. With a commitment to improving public health, Combi Putra aims to expand its export markets, particularly in Southeast Asia, and increase its global footprint. The company's vision is to become a leading pharmaceutical company in the region, known for its innovative products and dedication to quality and customer satisfaction.
Headquarters
RT 001 RW 10
Bandung; West Java;
Postal Code: 40224
Contact Details: Purchase the PT Combi Putra report to view the information.
Website: http://www.combiputra.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service